300
Participants
Start Date
September 30, 2002
Primary Completion Date
July 31, 2005
Study Completion Date
July 31, 2005
stavudine extended-release, lamivudine, efavirenz
Local Institution, Hobson City
Local Institution, Montgomery
Local Institution, Phoenix
Local Institution, Little Rock
Local Institution, Los Angeles
Local Institution, Sacramento
Local Institution, San Mateo
Local Institution, Torrance
Local Institution, Denver
Local Institution, Norwalk
Local Institution, Stratford
Local Institution, Washington D.C.
Local Institution, Fort Lauderdale
Local Institution, Miami
Local Institution, Miami Beach
Local Institution, Pensacola
Local Institution, Tampa
Local Institution, Decatur
Local Institution, Chicago
Local Institution, Indianapolis
Local Institution, New Orleans
Local Institution, Baltimore
Local Institution, Boston
Local Institution, Berkley
Local Institution, Detroit
Local Institution, St Louis
Local Institution, Las Vegas
Local Institution, Hackensack
Local Institution, Jersey City
Local Institution, Neptune City
Local Institution, Somers Point
Local Institution, Manhasset
Local Institution, New York
Local Institution, The Bronx
Local Institution, Charlotte
Local Institution, Huntersville
Local Institution, Washington
Local Institution, Winston-Salem
Local Institution, Philadelphia
Local Institution, Reading
Local Institution, Dallas
Local Institution, Galveston
Local Institution, Houston
Local Institution, Annandale
Local Institution, Hampton
Local Institution, Seattle
Local Institution, San Juan
Lead Sponsor
Bristol-Myers Squibb
INDUSTRY